Pantoprazole NEW
| Price | $30 | $40 | $65 |
| Package | 50mg | 100mg | 200mg |
| Min. Order: | |
| Supply Ability: | 10g |
| Update Time: | 2025-05-30 |
Product Details
| Product Name: Pantoprazole | CAS No.: 102625-70-7 |
| Purity: 99.28% | Supply Ability: 10g |
| Release date: 2025/05/30 |
Product Introduction
Bioactivity
| Name | Pantoprazole |
| Description | Pantoprazole (BY1023) is a proton pump inhibitor used for short-term treatment of erosion and ulceration of the esophagus caused by gastroesophageal reflux disease. |
| In vitro | PPZ(Pantoprazole) inhibits the proliferation of tumor cells, induces apoptosis and downregulates the expression of PKM2, which contributes to the current understanding of the functional association between PPZ and PKM2(The human M2 isoform of pyruvate kinase)[2]. Ex vivo studies showed that pantoprazole inhibited TOPK activities in JB6 Cl41 cells and HCT 116 colorectal cancer cells. Moreover, knockdown of TOPK in HCT 116 cells decreased their sensitivities to pantoprazole. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Solubility Information | DMSO : 50 mg/mL (130.42 mM), Sonication is recommended. Ethanol : 71 mg/mL (185.2 mM), Sonication is recommended. H2O : < 1 mg/mL (insoluble or slightly soluble) |
| Keywords | stability | SKF-96022 | SKF 96022 | release | Protonpump | Proton pump | Proton Pump | PPI | Pantoprazole | orally | MCF-7 | Inhibitor | inhibit | H+/K+-ATPase | exosome | Doxorubicin | BY-1023 | BY 1023 | Autophagy | Apoptosis | anti-ulcer | anti-secretory | A431 |
| Inhibitors Related | Stavudine | Cysteamine hydrochloride | Dextran sulfate sodium salt (MW 4500-5500) | Sodium 4-phenylbutyrate | Hydroxychloroquine | Guanidine hydrochloride | Tributyrin | Paeonol | Naringin | L-Ascorbic acid sodium salt | Alginic acid | Gefitinib |
| Related Compound Libraries | Highly Selective Inhibitor Library | Failed Clinical Trials Compound Library | Bioactive Compound Library | Membrane Protein-targeted Compound Library | Drug Repurposing Compound Library | Inhibitor Library | FDA-Approved Drug Library | Anti-Cancer Approved Drug Library | Bitter Compound library | Bioactive Compounds Library Max | Anti-Cancer Active Compound Library | Anti-Cancer Drug Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $/ |
VIP5Y
|
RongNa Biotechnology Co.,Ltd
|
2025-04-29 | |
| $0.00/1kg |
VIP4Y
|
Sinoway Industrial co., ltd.
|
2024-12-06 | |
| $35.00/1kg |
Sigma Audley
|
2024-03-15 | ||
| $50.00/1kg |
Henan Bao Enluo International TradeCo.，LTD
|
2023-08-02 | ||
| $15.00/1KG |
Zhuozhou Wenxi import and Export Co., Ltd
|
2021-07-10 | ||
| $444.00/1Kg/Bag |
Baoji Guokang Healthchem co.,ltd
|
2021-06-04 | ||
| $50.00/1KG |
Wuhan Monad Medicine Tech Co.,LTD
|
2021-04-16 | ||
| $1.00/1KG |
VIP6Y
|
Career Henan Chemical Co
|
2020-01-16 | |
| $15.00/1KG |
Zhuozhou Wenxi import and Export Co., Ltd
|
2021-07-09 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY